LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling.

Détails

ID Serval
serval:BIB_51606C2A9444
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling.
Périodique
Cancers
Auteur(s)
Kwan Y.P., Teo MHY, Lim JCW, Tan M.S., Rosellinny G., Wahli W., Wang X.
ISSN
2072-6694 (Print)
ISSN-L
2072-6694
Statut éditorial
Publié
Date de publication
30/06/2021
Peer-reviewed
Oui
Volume
13
Numéro
13
Pages
3279
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Although less common, melanoma is the deadliest form of skin cancer largely due to its highly metastatic nature. Currently, there are limited treatment options for metastatic melanoma and many of them could cause serious side effects. A better understanding of the molecular mechanisms underlying the complex disease pathophysiology of metastatic melanoma may lead to the identification of novel therapeutic targets and facilitate the development of targeted therapeutics. In this study, we investigated the role of leucine-rich α-2-glycoprotein 1 (LRG1) in melanoma development and progression. We first established the association between LRG1 and melanoma in both human patient biopsies and mouse melanoma cell lines and revealed a significant induction of LRG1 expression in metastatic melanoma cells. We then showed no change in tumour cell growth, proliferation, and angiogenesis in the absence of the host Lrg1. On the other hand, there was reduced melanoma cell metastasis to the lungs in Lrg1-deficient mice. This observation was supported by the promoting effect of LRG1 in melanoma cell migration, invasion, and adhesion. Mechanistically, LRG1 mediates melanoma cell invasiveness in an EGFR/STAT3-dependent manner. Taken together, our studies provided compelling evidence that LRG1 is required for melanoma metastasis but not growth. Targeting LRG1 may offer an alternative strategy to control malignant melanoma.
Mots-clé
EGFR, STAT3, leucine-rich α-2-glycoprotein-1, melanoma, metastasis
Pubmed
Web of science
Open Access
Oui
Création de la notice
12/07/2021 12:06
Dernière modification de la notice
24/07/2021 6:34
Données d'usage